Remove Company Remove Incubator Remove Startup Remove Thousand Oaks
article thumbnail

Amgen Backs Bay Area Life Science Incubator

socalTECH

Thousand Oaks-based biotech giant Amgen has put its backing behind a new, life sciences incubator, called QB3@953. According to Amgen, it will provide a five year, platinum sponsorship of the San Francisco life sciences incubator, to accelerate the development of new therapies to improve human health. READ MORE>>.

Incubator 113
article thumbnail

Amgen Lines Up Behind Two Bay Area Startups

socalTECH

Thousand Oaks-based Amgen is helping two, Bay Area startups, by offering up lab space and access to its scientific and business leaders, as part of a program called the "Amgen Golden Ticket", the company said on Tuesday. Amgen says it has been been sponsoring MBC BioLabs since 2016.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CLU's Gerhard Apfelthaler: What I Learned In 2014

socalTECH

We''re continuing to feature reflections on the last year from movers and shakers in the local high tech community, and today have thoughts from Gerhard Apfelthaler , who is Dean of California Lutheran University''s School of Management , which has been very active in Ventura County helping to promote startup and entrepreneurial activity.

article thumbnail

Southern California's Top 10 Most Popular Tech Stories Of The Year

socalTECH

in the company's efforts to start a commercial space tourism industry. 2011, showing a reduced number of exits--but more IPOs--in venture backed companies. It looks like people either loved, or really hated, the companies we featured. generation of startups. generation of startups. venture capital exits in.

article thumbnail

Biotech Roundup: ASCO, BIO, Drug Setbacks, Incubators & More

Xconomy

Plans for new incubators were announced in two different cities. The results give the company confidence it can expand its tests to screen for early cancer in high-risk people who are otherwise healthy. Biogen hasn’t given up on opicinumab yet, but shares tumbled more than 12 percent nonetheless.

article thumbnail

Makers Making The Sci-Fi Tricorder A Reality With VOXearch

socalTECH

We caught up with one of the local teams competing in that competition, VOXearch (www.voxearch.com), to learn more about the prize as well as their specific approach to the competition. Mike Outmesguine: We''re one of about thirty teams left in the challenge, out of more than 300 that signed up last August.

Startup 262